Department of Preventive Medicine, School of Medicine, Konkuk University, 1 Hwayang-dong, Gwangjin-gu, Seoul, 05029, South Korea.
Bigdata Steering Department, National Health Insurance Service, Wonju, South Korea.
Environ Health Prev Med. 2017 Mar 17;22(1):10. doi: 10.1186/s12199-017-0619-6.
The objective of this study was to assess the antihypertensive medication adherence in patients who were newly diagnosed with hypertension in Korea.
Study subjects were diagnosed with hypertension for the first time by the General Health Screening in 2012 and were 65,919. As indices, visiting rate to medical institution, the antihypertensive prescription rate, medication possession ratio and the rate of appropriate medication adherence were used. The qualification data, the General Health Screening data and the health insurance claims data were used.
Visiting rate to medical institution within one-year was 42.3%. Gender, age, family history of hypertension, smoking status, drinking frequency, insurance type, BMI, hypertension status, blood glucose level and LDL-cholesterol level were significant variables for visiting a medical institution. Of the study subjects who visited a medical institution, the antihypertensive prescription rate was 89.1%. Medication possession ratio was 70.9% and the rate of appropriate medication adherence was 60.6%. Age, family history of hypertension, smoking status, BMI level, hypertension level, blood glucose level, status, and LDL-cholesterol level were significant variables for the antihypertensive prescription and gender, age, family history of hypertension, smoking status, BMI, hypertension status, and the time of the first visit to a medical institution were significant variables for appropriate medication adherence.
This study showed that the antihypertensive medication adherence in patients who were newly diagnosed with hypertension was not relatively high in Korea. National Health Insurance Service should support an environment in which medical institutions and those diagnosed with hypertension can fulfill their roles.
本研究旨在评估韩国新诊断高血压患者的降压药物治疗依从性。
研究对象为 2012 年通过一般健康筛查首次诊断为高血压的患者,共 65919 例。以就诊率、降压药处方率、用药比例和适当用药依从率为指标。使用资格数据、一般健康筛查数据和健康保险索赔数据。
一年内就诊率为 42.3%。性别、年龄、高血压家族史、吸烟状况、饮酒频率、保险类型、BMI、高血压状况、血糖水平和 LDL-胆固醇水平是就诊的显著变量。在就诊的研究对象中,降压药处方率为 89.1%。用药比例为 70.9%,适当用药依从率为 60.6%。年龄、高血压家族史、吸烟状况、BMI 水平、高血压水平、血糖水平、就诊时间和 LDL-胆固醇水平是降压药处方的显著变量,性别、年龄、高血压家族史、吸烟状况、BMI、高血压状况和首次就诊时间是适当用药依从性的显著变量。
本研究表明,韩国新诊断高血压患者的降压药物治疗依从性相对较低。国家健康保险服务应支持医疗机构和高血压患者能够发挥作用的环境。